• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

菌血症患者的流行病学、临床和微生物学特征——对临床管理的启示

The Epidemiological, Clinical, and Microbiological Features of Patients with Bacteraemia-Implications for Clinical Management.

作者信息

Prinsloo Carmen, Smith Simon, Law Matthew, Hanson Josh

机构信息

College of Medicine and Dentistry, James Cook University, Cairns Hospital, Cairns, QLD 4870, Australia.

Department of Medicine, Cairns Hospital, Cairns, QLD 4870, Australia.

出版信息

Trop Med Infect Dis. 2023 Oct 24;8(11):481. doi: 10.3390/tropicalmed8110481.

DOI:10.3390/tropicalmed8110481
PMID:37999600
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10675116/
Abstract

Patients with melioidosis are commonly bacteraemic. However, the epidemiological characteristics, the microbiological findings, and the clinical associations of bacteraemia are incompletely defined. All cases of culture-confirmed melioidosis at Cairns Hospital in tropical Australia between January 1998 and June 2023 were reviewed. The presence of bacteraemia was determined and correlated with patient characteristics and outcomes; 332/477 (70%) individuals in the cohort were bacteraemic. In multivariable analysis, immunosuppression (odds ratio (OR) (95% confidence interval (CI)): (2.76 (1.21-6.27), = 0.02), a wet season presentation (2.27 (1.44-3.59), < 0.0001) and male sex (1.69 (1.08-2.63), = 0.02), increased the likelihood of bacteraemia. Patients with a skin or soft tissue infection (0.32 (0.19-0.57), < 0.0001) or without predisposing factors for melioidosis (0.53 (0.30-0.93), = 0.03) were less likely to be bacteraemic. Bacteraemia was associated with intensive care unit admission (OR (95%CI): 4.27 (2.35-7.76), < 0.0001), and death (2.12 (1.04-4.33), = 0.04). The median (interquartile range) time to blood culture positivity was 31 (26-39) hours. Patients with positive blood cultures within 24 h were more likely to die than patients whose blood culture flagged positive after this time (OR (95%CI): 11.05 (3.96-30.83), < 0.0001). Bacteraemia portends a worse outcome in patients with melioidosis. Its presence or absence might be used to help predict outcomes in cases of melioidosis and to inform optimal clinical management.

摘要

类鼻疽患者通常会出现菌血症。然而,菌血症的流行病学特征、微生物学发现及临床关联尚未完全明确。对1998年1月至2023年6月期间澳大利亚热带地区凯恩斯医院所有经培养确诊的类鼻疽病例进行了回顾性研究。确定菌血症的存在情况,并将其与患者特征及预后相关联;该队列中有332/477(70%)的个体出现菌血症。在多变量分析中,免疫抑制(比值比(OR)(95%置信区间(CI)):(2.76(1.21 - 6.27),P = 0.02)、雨季发病(2.27(1.44 - 3.59),P < 0.0001)和男性(1.69(1.08 - 2.63),P = 0.02)会增加菌血症的发生可能性。患有皮肤或软组织感染的患者(0.32(0.19 - 0.57),P < 0.0001)或无类鼻疽易感因素的患者(0.53(0.30 - 0.93),P = 0.03)发生菌血症的可能性较小。菌血症与入住重症监护病房相关(OR(95%CI):4.27(2.35 - 7.76),P < 0.0001),且与死亡相关(2.12(1.04 - 4.33),P = 0.04)。血培养阳性的中位(四分位间距)时间为31(26 - 39)小时。血培养在24小时内呈阳性的患者比血培养在此时间之后呈阳性的患者死亡可能性更高(OR(95%CI):11.05(3.96 - 30.83),P < 0.0001)。菌血症预示着类鼻疽患者的预后更差。其存在与否可用于帮助预测类鼻疽病例的预后,并为优化临床管理提供依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3bc/10675116/512980a96441/tropicalmed-08-00481-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3bc/10675116/0ef0e872aed4/tropicalmed-08-00481-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3bc/10675116/512980a96441/tropicalmed-08-00481-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3bc/10675116/0ef0e872aed4/tropicalmed-08-00481-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a3bc/10675116/512980a96441/tropicalmed-08-00481-g002.jpg

相似文献

1
The Epidemiological, Clinical, and Microbiological Features of Patients with Bacteraemia-Implications for Clinical Management.菌血症患者的流行病学、临床和微生物学特征——对临床管理的启示
Trop Med Infect Dis. 2023 Oct 24;8(11):481. doi: 10.3390/tropicalmed8110481.
2
Melioidosis-a disease of socioeconomic disadvantage.类鼻疽——一种与社会经济劣势相关的疾病。
PLoS Negl Trop Dis. 2021 Jun 21;15(6):e0009544. doi: 10.1371/journal.pntd.0009544. eCollection 2021 Jun.
3
The Darwin Prospective Melioidosis Study: a 30-year prospective, observational investigation.达尔文前瞻性类鼻疽病研究:一项 30 年的前瞻性观察性研究。
Lancet Infect Dis. 2021 Dec;21(12):1737-1746. doi: 10.1016/S1473-3099(21)00022-0. Epub 2021 Jul 22.
4
Bone and joint infections due to melioidosis; diagnostic and management strategies to optimise outcomes.类鼻疽所致骨与关节感染;优化治疗效果的诊断与管理策略
PLoS Negl Trop Dis. 2024 Jul 17;18(7):e0012317. doi: 10.1371/journal.pntd.0012317. eCollection 2024 Jul.
5
Clinical characteristics and predictors of mortality in patients with melioidosis: the Kapit experience.类鼻疽病患者的临床特征和死亡预测因素:加帛经验。
Trop Med Int Health. 2021 Jun;26(6):664-671. doi: 10.1111/tmi.13563. Epub 2021 Mar 3.
6
A retrospective analysis of melioidosis in Cambodian children, 2009-2013.2009 - 2013年柬埔寨儿童类鼻疽病的回顾性分析。
BMC Infect Dis. 2016 Nov 21;16(1):688. doi: 10.1186/s12879-016-2034-9.
7
Melioidosis of the central nervous system; impact of the bimABm allele on patient presentation and outcome.中枢神经系统类鼻疽;bimABm等位基因对患者表现及预后的影响。
Clin Infect Dis. 2022 Feb 7. doi: 10.1093/cid/ciac111.
8
Bacteraemic melioidosis pneumonia: impact on outcome, clinical and radiological features.菌血症性类鼻疽肺炎:对预后、临床及影像学特征的影响
J Infect. 2004 May;48(4):334-8. doi: 10.1016/j.jinf.2003.10.005.
9
Improving the clinical recognition, prognosis, and treatment of melioidosis through epidemiology and clinical findings: The Sabah perspective.通过流行病学和临床发现改善类鼻疽的临床识别、预后和治疗:沙巴视角。
PLoS Negl Trop Dis. 2023 Oct 16;17(10):e0011696. doi: 10.1371/journal.pntd.0011696. eCollection 2023 Oct.
10
Clinical characteristics and prognosis of bacteraemia during postoperative intra-abdominal infections.术后腹腔感染时菌血症的临床特征和预后。
Crit Care. 2018 Jul 7;22(1):175. doi: 10.1186/s13054-018-2099-5.

引用本文的文献

1
The Association Between Statin Therapy and the Subsequent Clinical Course of Patients With Melioidosis.他汀类药物治疗与类鼻疽病患者后续临床病程之间的关联。
J Trop Med. 2025 May 25;2025:8838580. doi: 10.1155/jotm/8838580. eCollection 2025.
2
The Incidence, Aetiology and Clinical Course of Serious Infections Complicating Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drug Therapy in Patients with Rheumatoid Arthritis in Tropical Australia.澳大利亚热带地区类风湿关节炎患者生物制剂和靶向合成改善病情抗风湿药物治疗并发严重感染的发病率、病因及临床病程
Pathogens. 2024 Oct 29;13(11):943. doi: 10.3390/pathogens13110943.
3

本文引用的文献

1
Burkholderia pseudomallei and melioidosis.伯克霍尔德氏菌和类鼻疽。
Nat Rev Microbiol. 2024 Mar;22(3):155-169. doi: 10.1038/s41579-023-00972-5. Epub 2023 Oct 4.
2
The seasonality of infections in tropical Far North Queensland, Australia: A 21-year retrospective evaluation of the seasonal patterns of six endemic pathogens.澳大利亚昆士兰远北热带地区感染的季节性:对六种地方病原体季节性模式的21年回顾性评估
PLOS Glob Public Health. 2022 May 25;2(5):e0000506. doi: 10.1371/journal.pgph.0000506. eCollection 2022.
3
Characteristics and One Year Outcomes of Melioidosis Patients in Northeastern Thailand: A Prospective, Multicenter Cohort Study.
The characteristics and clinical course of patients with melioidosis and cancer.
类鼻疽病合并癌症患者的特征和临床病程。
PLoS Negl Trop Dis. 2024 Oct 25;18(10):e0012631. doi: 10.1371/journal.pntd.0012631. eCollection 2024 Oct.
4
Bone and joint infections due to melioidosis; diagnostic and management strategies to optimise outcomes.类鼻疽所致骨与关节感染;优化治疗效果的诊断与管理策略
PLoS Negl Trop Dis. 2024 Jul 17;18(7):e0012317. doi: 10.1371/journal.pntd.0012317. eCollection 2024 Jul.
泰国东北部类鼻疽患者的特征及一年预后:一项前瞻性多中心队列研究
Lancet Reg Health Southeast Asia. 2023 Feb;9. doi: 10.1016/j.lansea.2022.100118. Epub 2022 Nov 25.
4
The efficacy and safety of a shortened duration of antimicrobial therapy for group A Streptococcus bacteremia.A组链球菌菌血症抗菌治疗疗程缩短的疗效与安全性
Int J Infect Dis. 2023 Mar;128:11-19. doi: 10.1016/j.ijid.2022.12.015. Epub 2022 Dec 16.
5
Source control in the management of sepsis and septic shock.脓毒症和感染性休克管理中的源头控制
Intensive Care Med. 2022 Dec;48(12):1799-1802. doi: 10.1007/s00134-022-06852-5. Epub 2022 Sep 14.
6
Examination of the independent contribution of rheumatic heart disease and congestive cardiac failure to the development and outcome of melioidosis in Far North Queensland, tropical Australia.在澳大利亚热带地区的北昆士兰,检查风湿性心脏病和充血性心力衰竭对类鼻疽病的发展和结果的独立贡献。
PLoS Negl Trop Dis. 2022 Jul 18;16(7):e0010604. doi: 10.1371/journal.pntd.0010604. eCollection 2022 Jul.
7
Time to Blood Culture Positivity: An Independent Predictor of Mortality in Bacteremia.血培养阳性时间:菌血症患者死亡率的独立预测因素
Open Forum Infect Dis. 2022 Apr 3;9(6):ofac163. doi: 10.1093/ofid/ofac163. eCollection 2022 Jun.
8
Prevalence of carbapenem resistance and its potential association with antimicrobial use in humans and animals in rural communities in Vietnam.越南农村社区中碳青霉烯类耐药性的流行情况及其与人类和动物抗菌药物使用的潜在关联。
JAC Antimicrob Resist. 2022 Apr 19;4(2):dlac038. doi: 10.1093/jacamr/dlac038. eCollection 2022 Apr.
9
Melioidosis of the central nervous system; impact of the bimABm allele on patient presentation and outcome.中枢神经系统类鼻疽;bimABm等位基因对患者表现及预后的影响。
Clin Infect Dis. 2022 Feb 7. doi: 10.1093/cid/ciac111.
10
Increased Incidence of Melioidosis in Far North Queensland, Queensland, Australia, 1998-2019.1998-2019 年澳大利亚昆士兰州远北地区类鼻疽病发病率上升。
Emerg Infect Dis. 2021 Dec;27(12):3119-3123. doi: 10.3201/eid2712.211302.